NCT00481039

Brief Summary

Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel. The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 31, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 1, 2007

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

September 4, 2009

Status Verified

September 1, 2009

Enrollment Period

1.6 years

First QC Date

May 31, 2007

Last Update Submit

September 3, 2009

Conditions

Sickle Cell Disease

Keywords

Sickle cell diseaseSickle cell thalassemiaPopulation screening

Study Arms (1)

1

Patients diagnosed as having abnormal hemoglobin like hemoglobin S and thalassemia in a bedouin village

Procedure: Medical history and basic laboratory analysis

Interventions

Medical history and basic laboratory analysisPROCEDURE

Medical history and basic laboratory analysis

1

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All the patients diagnosed with abnormal hemoglobin in the bedouin arab village

You may qualify if:

  • All the patients that were diagnosed as having sickle cell disease in the specific village and all the population screened for hemoglobinopathies in the same location

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Hematology Unit - HaEmek Medical Center

Afula, 18101, Israel

Location

MeSH Terms

Conditions

Anemia, Sickle Cell

Interventions

Health Records, Personal

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Medical RecordsRecordsData CollectionEpidemiologic MethodsInvestigative Techniques

Study Officials

  • Ariel Koren, MD

    Pediatric Hematology Unit, Ha'Emek Medical Center

    STUDY DIRECTOR

  • luci Zalman, Phd

    Hematology Laboratory - HaEmek Medical Center

    STUDY CHAIR

  • Tania Flaishman, Student

    Pediatric Dpt B - Ha'Emek Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 31, 2007

First Posted

June 1, 2007

Study Start

May 1, 2007

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

September 4, 2009

Record last verified: 2009-09

Locations

IL(1)